81 related articles for article (PubMed ID: 196497)
1. Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
Trabucchi M; Andreoli VM; Frattola L; Spano PF
Adv Biochem Psychopharmacol; 1977; 16():661-5. PubMed ID: 196497
[No Abstract] [Full Text] [Related]
2. New central dopamine agonists.
Borsy J
Pol J Pharmacol Pharm; 1985; 37(3):227-36. PubMed ID: 2999737
[TBL] [Abstract][Full Text] [Related]
3. A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
Jaton AL; Loew DM; Vigouret JM
Br J Pharmacol; 1978 Mar; 62(3):395P. PubMed ID: 565235
[No Abstract] [Full Text] [Related]
4. Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
Loew DM; Jaton AL; Vigouret JM
Postgrad Med J; 1976; 52suppl 1():40-46. PubMed ID: 822407
[No Abstract] [Full Text] [Related]
5. Regulatory peptides in animal paradigms of neuropsychiatric illness.
Diamond BI; Borison RL
Adv Biochem Psychopharmacol; 1982; 33():541-8. PubMed ID: 6214928
[No Abstract] [Full Text] [Related]
6. Bromocriptin and methylergometrine: pharmacological approach of the mechanism of their central effects.
Puech AJ; Simon P; Chermat R; Boissier JR
Pharmacol Res Commun; 1977 Mar; 9(3):299-306. PubMed ID: 577309
[No Abstract] [Full Text] [Related]
7. The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
Lemberger L; Kellams JJ; Small JG; Rowe H
Commun Psychopharmacol; 1977; 1(5):501-7. PubMed ID: 564259
[No Abstract] [Full Text] [Related]
8. Animal model of depression: imipramine, bromocriptine and lisuride alleviate motor depression.
Golda V; Petr R; Rozsíval V; Suba P
Act Nerv Super (Praha); 1986 Mar; 28(1):26-7. PubMed ID: 3727904
[No Abstract] [Full Text] [Related]
9. Growth hormone secretion in neurological disorders.
Martinez-Campos A; Giovannini P; Cocchi D; Zanardi P; Parati EA; Caraceni T; Müller EE
Adv Biochem Psychopharmacol; 1981; 28():521-40. PubMed ID: 6452036
[No Abstract] [Full Text] [Related]
10. Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
Bergmann F
Isr J Med Sci; 1982 Jan; 18(1):177-82. PubMed ID: 6121772
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
Wray SR; Melville GN; Grell GA; Edge PC
West Indian Med J; 1981 Sep; 30(3):107-18. PubMed ID: 6117153
[No Abstract] [Full Text] [Related]
12. Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.
Silbergeld EK; Pfeiffer RF
J Neurochem; 1977 Jun; 28(6):1323-6. PubMed ID: 577501
[No Abstract] [Full Text] [Related]
13. Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
Hutt CS; Snider SR; Fahn S
Neurology; 1977 Jun; 27(6):503-10. PubMed ID: 577299
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine:dopamine-receptor agonist.
Dipalma JR
Am Fam Physician; 1976 Dec; 14(6):88-9. PubMed ID: 1036662
[No Abstract] [Full Text] [Related]
15. Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].
Dolphin AC; Jenner P; Marsden CD; Sawaya MC
Br J Pharmacol; 1977 Mar; 59(3):467P. PubMed ID: 576587
[No Abstract] [Full Text] [Related]
16. Effect of AT II on the exploratory behaviour of rats. Interactions with elymoclavine and bromocryptine.
Petkova B; Georgiev V; Kambourova T
Acta Physiol Pharmacol Bulg; 1991; 17(2-3):84-90. PubMed ID: 1819920
[TBL] [Abstract][Full Text] [Related]
17. Bromocriptine - an important advance.
Drug Ther Bull; 1976 Apr; 14(9):33-4. PubMed ID: 1278002
[No Abstract] [Full Text] [Related]
18. Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism.
Di Chiara G; Vargiu L; Porceddu ML; Gessa GL
Adv Biochem Psychopharmacol; 1977; 16():443-6. PubMed ID: 578073
[No Abstract] [Full Text] [Related]
19. Pharmacological characterization of CB 154.
Triangle; 1975; 14(3-4):153-7. PubMed ID: 1209735
[No Abstract] [Full Text] [Related]
20. On some central effects of elymoclavine.
Roussinov K; Georgiev V; Petkov V; Lazarova M; Petkova B; Shopova S; Markovska V; Getova D; Draganova S
Acta Physiol Pharmacol Bulg; 1984; 10(4):28-35. PubMed ID: 6442955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
